Pharma Industry in Crisis: How to Preserve Quality While Balancing Budget and Time in Today’s Financial Climate

Date: Wednesday, July 16, 2025 11am–12pm EDT
Event Location: Virtual

With venture funding tightening in the post-COVID landscape, efficiency has become more critical than ever. To make limited capital go further, companies must meet key development milestones swiftly and successfully—unlocking the next stages of funding through high-quality, timely data.

In this interactive webinar hosted by BioSpace, industry experts will explore actionable strategies for maintaining quality under financial pressure. Marina Galvani, VP of Scientific Strategy at Evotec, will share her deep expertise in integrated drug development. She will be joined by Josh Gillum, VP of Business Development at Evotec, who will provide insights drawn from his experience leading 16 INDs through to multiple mid-phase clinical trials.

Don’t miss this opportunity to engage directly with leaders in the field and gain valuable perspectives on how to navigate today’s challenging market. Live Q&A will be available throughout the session.

Marina Galvani

Vice President Scientific Strategy | Evotec

Marina has 25 years of experience in pharmaceutical development, supporting the progression of new chemical entities from candidate selection through clinical phases.

She began her career as a Scientist at GlaxoSmithKline, gaining a strong foundation in drug substance and drug product analytics, including pre-formulation, degradation chemistry, and stability studies. As a CMC Leader at Aptuit and later a Scientific Project Leader at Evotec, she oversaw more than 40 integrated development programs.

In her current role as Vice President of Scientific Strategy, Marina serves as a senior development expert, supporting business development efforts and the design of customized integrated development plans for partners. She also contributes to the continuous evolution of Evotec’s integrated service offerings.

Joshua Gillum

Vice President Business Development

Josh joined Evotec’s Business Development team in 2019, bringing nearly 20 years of experience as a drug developer in the Boston/Cambridge biotechnology hub.

Prior to Evotec, he held leadership roles at Idenix Pharmaceuticals, Dimension Therapeutics, and Navitor Pharmaceuticals. In these positions, he was a long-standing client of Evotec and its subsidiary Aptuit, successfully leading five IND-enabling development programs utilizing Evotec’s integrated platform.

Since joining Evotec, Josh has leveraged his deep drug development expertise to enhance client relationships and align Evotec’s offerings with partner expectations.

He currently serves as Vice President of Business Development, supporting partners in New York, Connecticut, Massachusetts, and Eastern Canada.

Lori Ellis

Head of Insights | BioSpace

Lori is the head of insights at BioSpace. She analyzes and comments on industry trends for BioSpace and clients. She creates engaging content for clients to support their marketing objectives. She has been part of an award-winning marketing team and has won a Muse Creative award, a Vega award and several Adobe awards in collaborative team projects for her audio narration work. Her experience in the television/film and audio industries benefits both BioSpace and partners through her moderation and hosting of live and virtual events. While she has covered all elements of the drug development process, her primary focuses are women’s health issues, the economic climate, and the ever-evolving impact of technology – specifically artificial intelligence – on the pharmaceutical industry.